MOLECULAR-GENETIC FACTORS, ASSOCIATED WITH AORTIC STENOSIS DEVELOPMENT

Aortic stenosis (AS) is one of the most prevalent valvular heart disorders in patients older than 65 years. Regardless the studied molecular mechanisms of development and progression of the disease, surgical treatment is recently the only successful method of help. Due to lots of comorbidities of ol...

Full description

Bibliographic Details
Main Authors: T. A. Tipteva, O. S. Chumakova, D. A. Zateyshchikov
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC  2015-10-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/325
id doaj-79e840f084f3438d9589e917a8afc8d3
record_format Article
spelling doaj-79e840f084f3438d9589e917a8afc8d32021-07-28T14:02:24Zrus«FIRMA «SILICEA» LLC Российский кардиологический журнал1560-40712618-76202015-10-010109910610.15829/1560-4071-2015-10-99-106325MOLECULAR-GENETIC FACTORS, ASSOCIATED WITH AORTIC STENOSIS DEVELOPMENTT. A. Tipteva0O. S. Chumakova1D. A. Zateyshchikov2Central state medical Academy of the administrative Department of the President of the Russian Federation, MoscowCentral state medical Academy of the administrative Department of the President of the Russian Federation, MoscowCity Clinical Hospital №51, Moscow; Central state medical Academy of the administrative Department of the President of the Russian Federation, Moscow; Federal scientific-clinical center of specialized types of clinical care and medical technologies of FMBA of Russia, MoscowAortic stenosis (AS) is one of the most prevalent valvular heart disorders in patients older than 65 years. Regardless the studied molecular mechanisms of development and progression of the disease, surgical treatment is recently the only successful method of help. Due to lots of comorbidities of older patients, there are obstacles to recommend surgical valve replacement, even knowing an adverse prognosis of conservative treatment. Search for new approaches to earlier assessment of adverse risk factors, speed of progression of this disease, would help to evaluate the necessity of earlier treatment and could make to slow down the progression of the disease. One of directions for this — is a search for genetic markers. This review focuses on the main known molecular mechanisms and genetic markers related to them, that are associated with AS.https://russjcardiol.elpub.ru/jour/article/view/325aortic stenosishereditary predisposition
collection DOAJ
language Russian
format Article
sources DOAJ
author T. A. Tipteva
O. S. Chumakova
D. A. Zateyshchikov
spellingShingle T. A. Tipteva
O. S. Chumakova
D. A. Zateyshchikov
MOLECULAR-GENETIC FACTORS, ASSOCIATED WITH AORTIC STENOSIS DEVELOPMENT
Российский кардиологический журнал
aortic stenosis
hereditary predisposition
author_facet T. A. Tipteva
O. S. Chumakova
D. A. Zateyshchikov
author_sort T. A. Tipteva
title MOLECULAR-GENETIC FACTORS, ASSOCIATED WITH AORTIC STENOSIS DEVELOPMENT
title_short MOLECULAR-GENETIC FACTORS, ASSOCIATED WITH AORTIC STENOSIS DEVELOPMENT
title_full MOLECULAR-GENETIC FACTORS, ASSOCIATED WITH AORTIC STENOSIS DEVELOPMENT
title_fullStr MOLECULAR-GENETIC FACTORS, ASSOCIATED WITH AORTIC STENOSIS DEVELOPMENT
title_full_unstemmed MOLECULAR-GENETIC FACTORS, ASSOCIATED WITH AORTIC STENOSIS DEVELOPMENT
title_sort molecular-genetic factors, associated with aortic stenosis development
publisher «FIRMA «SILICEA» LLC 
series Российский кардиологический журнал
issn 1560-4071
2618-7620
publishDate 2015-10-01
description Aortic stenosis (AS) is one of the most prevalent valvular heart disorders in patients older than 65 years. Regardless the studied molecular mechanisms of development and progression of the disease, surgical treatment is recently the only successful method of help. Due to lots of comorbidities of older patients, there are obstacles to recommend surgical valve replacement, even knowing an adverse prognosis of conservative treatment. Search for new approaches to earlier assessment of adverse risk factors, speed of progression of this disease, would help to evaluate the necessity of earlier treatment and could make to slow down the progression of the disease. One of directions for this — is a search for genetic markers. This review focuses on the main known molecular mechanisms and genetic markers related to them, that are associated with AS.
topic aortic stenosis
hereditary predisposition
url https://russjcardiol.elpub.ru/jour/article/view/325
work_keys_str_mv AT tatipteva moleculargeneticfactorsassociatedwithaorticstenosisdevelopment
AT oschumakova moleculargeneticfactorsassociatedwithaorticstenosisdevelopment
AT dazateyshchikov moleculargeneticfactorsassociatedwithaorticstenosisdevelopment
_version_ 1721269234341773312